OC
VNRX icon

Oppenheimer & Co’s VolitionRx Ltd VNRX Stock Holding History

Oppenheimer & Co’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-939
Closed -$60K – 1408
2020
Q3 		$60K Hold
939
– – ﹤0.01% 1254
2020
Q2 		$73K Buy
939
+291
+45% +$21K ﹤0.01% 1223
2020
Q1 		$40K Hold
648
– – ﹤0.01% 1161
2019
Q4 		$61K Buy
648
+10
+2% +$1.04K ﹤0.01% 1251
2019
Q3 		$72K Sell
638
-1,344
-68% -$107K ﹤0.01% 1225
2019
Q2 		$124K Buy
1,982
+75
+4% +$4.86K ﹤0.01% 1251
2019
Q1 		$124K Sell
1,907
-26
-1% -$1.45K ﹤0.01% 1292
2018
Q4 		$70K Buy
1,933
+85
+5% +$4.04K ﹤0.01% 1199
2018
Q3 		$96K Hold
1,848
– – ﹤0.01% 1309
2018
Q2 		$74K Buy
+1,848
New +$82.6K ﹤0.01% 1298

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Oppenheimer & Co's VNRX Position: Q4 2020 in Review

Oppenheimer & Co sold out of VolitionRx Ltd (VNRX) in Q4 2020, closing a stake of 939 shares — an estimated $60K sold.

Oppenheimer & Co first reported a position in VNRX in Q2 2018 and held it in 10 quarters. The position peaked at $124K in Q2 2019. 45 funds tracked by Wall St. Rank hold VNRX as of Q4 2020.

  • Oppenheimer & Co reported no remaining VolitionRx Ltd position as of Q4 2020 after selling out during the quarter.
  • Oppenheimer & Co sold 939 VolitionRx Ltd shares in Q4 2020, an estimated $60K.
  • Oppenheimer & Co first reported a position in VolitionRx Ltd in Q2 2018 and held it in 10 quarters.
  • Oppenheimer & Co's VolitionRx Ltd position peaked at $124K in Q2 2019.
  • 45 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2020.

Based on Oppenheimer & Co's 13F filing for Q4 2020, filed 11 Feb 2021.